Evidence map›Paper›PMID 19027033›Full record

ArticleToxicology and applied pharmacology2009

Arginase enzymes in isolated airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbumin.

Jennifer M Bratt, Lisa M Franzi, Angela L Linderholm, Michael S Last, Nicholas J Kenyon, Jerold A Last

Open access · greenAbstract read
In one paragraph

Article in Toxicology and applied pharmacology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Soluble epoxide hydrolase inhibitor attenuates inflammation and airway hyperresponsiveness in mice.American journal of respiratory cell and molecular biology · 2015
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. TGF-β2 reduces nitric oxide synthase mRNA through a ROCK-dependent pathway in airway epithelial cells.American journal of physiology. Lung cellular and molecular physiology · 2011
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jennifer M BrattDepartment of Pulmonary and Critical Care Medicine, CCRBM, School of Medicine, University of California, Davis, CA 95616, USA.
Lisa M Franzi
Angela L Linderholm
Michael S Last
Nicholas J Kenyon
Jerold A Last
University of California, Davis · US

Funding

UC DAVIS CLINICAL AND TRANSLATIONAL SCIENCE CENTER: BPCAUL1RR024146 · NCRR · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERGLUND, LARS F · 2006 to 2011
$27.0M
NIEHS Center for Health Effects of AgrochemicalsP30ES005707 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI PESSAH, ISAAC N · 1992 to 2006
$9.9M
International Training Program in Environmental Toxicology and Public HealthD43TW005718 · FIC · UNIVERSITY OF CALIFORNIA DAVIS · PI LAST, JEROLD ALAN · 2001 to 2011
$1.7M
PROTECTIVE ROLE FOR NITRIC OXIDE IN AIRWAY INFLAMMATIONK08HL076415 · NHLBI · UNIVERSITY OF CALIFORNIA DAVIS · PI KENYON, NICHOLAS J. · 2005 to 2009
$617k
MECHANISMS OF OXIDANT INDUCED LYMPHOCYTE REGULATIONF32ES005707 · NIEHS · WADSWORTH CENTER · PI KRIEGER, JIM A · 1995 to 1996
–
FIC NIH HHS D43 TW005718FIC NIH HHS TW-05718NCRR NIH HHS UL1 RR024146NCRR NIH HHS UL1RR024146NHLBI NIH HHS K08 HL-076415NHLBI NIH HHS K08 HL076415NIEHS NIH HHS ES-05707NIEHS NIH HHS F32 ES005707NIEHS NIH HHS P30 ES005707
6 · The paper itself

Abstract

Arginase has been suggested to compete with nitric oxide synthase (NOS) for their common substrate, l-arginine. To study the mechanisms underlying this interaction, we compared arginase expression in isolated airways and the consequences of inhibiting arginase activity in vivo with NO production, lung inflammation, and lung function in both C57BL/6 and NOS2 knockout mice undergoing ovalbumin-induced airway inflammation, a mouse model of asthma. Arginases I and II were measured by western blot in isolated airways from sensitized C57BL/6 mice exposed to ovalbumin aerosol. Physiological and biochemical responses - inflammation, lung compliance, airway hyperreactivity, exhaled NO concentration, arginine concentration - were compared with the responses of NOS2 knockout mice. NOS2 knockout mice had increased total cells in lung lavage, decreased lung compliance, and increased airway hyperreactivity. Both arginase I and arginase II were constitutively expressed in the airways of normal C57BL/6 mice. Arginase I was up-regulated approximately 8-fold in the airways of C57BL/6 mice exposed to ovalbumin. Expression of both arginase isoforms were significantly upregulated in NOS2 knockout mice exposed to ovalbumin, with about 40- and 4-fold increases in arginases I and II, respectively. Arginine concentration in isolated airways was not significantly different in any of the groups studied. Inhibition of arginase by systemic treatment of C57BL/6 mice with a competitive inhibitor, Nomega-hydroxy-nor-l-arginine (nor-NOHA), significantly decreased the lung inflammatory response to ovalbumin in these animals. We conclude that NOS2 knockout mice are more sensitive to ovalbumin-induced airway inflammation and its sequelae than are C57BL/6 mice, as determined by increased total cells in lung lavage, decreased lung compliance, and increased airway hyperreactivity, and that these findings are strongly correlated with increased expression of both arginase isoforms in the airways of the NOS2 knockout mice exposed to ovalbumin.

Indexed as

AnimalsArginaseArginineAsthmaBreath TestsBronchial HyperreactivityBronchial Provocation TestsBronchoalveolar Lavage FluidDisease Models, AnimalEnzyme InhibitorsLungLung ComplianceMaleMiceMice, Inbred C57BLMice, KnockoutArg2 protein, mouseArginaseArginineEnzyme InhibitorsNitric OxideNitric Oxide Synthase Type IIN(omega)-hydroxynorarginineNos2 protein, mouseOvalbumin

Identifiers

PMID19027033
PMCPMC2666129
OpenAlexW2034616121

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.